Dr Agarwal’s Healthcare allotment today: How to check allotment status online on BSE, NSE, KFin Technologies

Dr Agarwal’s Healthcare, recently concluded its IPO. The company’s public issue, which opened for bidding on January 29, closed on January 31, with a price band set between the range of Rs 382 to Rs 402 per share.

The allotment status is likely to be finalised on today, February 3. Those who get allotted shares will see them credited to their demat accounts before the listing date. Dr Agarwals Healthcare shares are set to list on both the BSE and NSE on February 5.

How to Check Dr Agarwals Healthcare IPO Allotment Status

Investors who applied for shares in Dr Agarwals Healthcare IPO can check the allotment status online through multiple platforms such as BSE, NSE or the registrar, KFin Technologies. Here’s the step by step guide to check the status:

– Via BSE

  • Go to BSE’s IPO allotment page: BSE IPO Status
  • Select ‘Equity’ as the issue type
  • Choose ‘Dr Agarwal’s Healthcare Ltd’ from the IPO names list
  • Enter your PAN Number or Application Number
  • Click on ‘Submit’ to check if you have been allotted shares

Also ReadUpcoming IPOs this week: 5 new SME issues and 2 listings to watch – Via NSE

  • Visit NSE’s bid verification portal: NSE IPO Status
  • Select ‘Dr Agarwal’s Healthcare Ltd’
  • Enter your Application Number and PAN Number
  • Click on ‘Submit’ to view the status

– Via  KFin Technologies

  • Visit the IPO allotment status page: KFin Technologies IPO Status
  • Select ‘Dr Agarwal’s Healthcare Ltd’ from the IPO dropdown list
  • Enter your PAN, Application Number, DP ID, or Account Number
  • Fill in the required details for verification
  • Click on ‘Submit’ to check your allotment status

Dr Agarwal IPO: Subscription and GMP Trends

Dr Agarwals Healthcare IPO received a subscription of 1.49 times by the end of the bidding period. Breaking it down, QIBs portion saw a subscription rate of 4.41 times, NII portion was booked 0.39 times and the retail portion received a subscription rate of 0.42 times.

GMP: As per the latest GMP trends, the stock is trading at a Rs 1.5 premium, hinting at a listing price of around Rs 403.5 per share.

 » Read More

Related Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…

Jefferies has maintained a Buy on JB Pharma with a revised target price of Rs 2,310. The stock currently trades at Rs 1,714/share implying an 34% upside. This new target price is just a shade lower than the previous target price of Rs 2,340. According to Jefferies, an international brokerage house, the growth drivers are

Two banking stocks to watch ahead of the RBI Policy

By Kiran Jani Bank Nifty reached its all-time high of 54,467 in September 2024. Following this peak, the index experienced a correction, dipping to 47,844 in January 2025—a decline of 7.29%. Despite this pullback, Kotak Bank and ICICI Bank showed relative resilience, delivering returns of 1.61% and -4.20%, respectively, during the same period. Source: Investing.com

New Tax Regime: These deductions, exemptions still available for you

The Indian government introduced a new tax regime in 2020, offering lower tax rates while removing several exemptions and deductions available under the old system. Initially optional, this regime became the default in 2023, requiring taxpayers to opt out if they wished to continue under the old structure. Despite the removal of many benefits, certain

Range bound session: Nifty ends above 23,600, Sensex holds 78,000 led by Adani Ports, Infosys

The stock markets faced a downturn on Thursday, with major indices closing in the red. The BSE Sensex dropped by 213.12 points or 0.27%, ending the day at 78,058.16, while the NSE Nifty 50 saw a decline of 70.15 points, down by 0.3%, and closed at 23,626.15. The Nifty Bank index also ended the day

IT stocks stable as Cognizant raises annual and quarterly revenue guidance

Shares of Indian IT companies are in the spotlight today after the Nasdaq-listed IT services major Cognizant Technology Solutions, reported its Q4 results that exceeded Wall Street expectations. The Nifty IT Index as well as individual tech counters like Infosys, Wipro, Tech Mahindra and HCL Tech are all in the green even as the markets